« Back
Home /
ADL-5859 (hydrochloride)

ADL-5859 (hydrochloride)

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 mg
Item no.	HY-13044-5mg
Targets	Opioid Receptor
CASRN	850173-95-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	ADL-5859 hydrochloride (compound 20) is a selective and orally active δ opioid receptor (DOR) agonist with an Ki and an EC50 value of 0.84 and 20 nM, respectively. ADL-5859 hydrochloride also shows inhibitory activity to hERG channel with an IC50 value of 78 μM. ADL-5859 hydrochloride can be used for the research of pain[1][2].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	428.95
Clinical_Information	Phase 2
Manufacturers Research_Area	Inflammation/Immunology; Neurological Disease
Solubility	DMSO : ≥ 100 mg/mL\|H2O : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	Cytochrome P450; Opioid Receptor; Potassium Channel
Isoform	δ Opioid Receptor/DOR
Pathway	GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13044-5mg-safety-datasheet.pdf